首页> 外文期刊>The Journal of Urology >Re: EPCA-2: A highly specific serum marker for prostate cancer
【24h】

Re: EPCA-2: A highly specific serum marker for prostate cancer

机译:回复:EPCA-2:前列腺癌的高度特异性血清标志物

获取原文
获取原文并翻译 | 示例
           

摘要

This article has been retracted at the request of the authors. They believe that the article contains findings that may be unreliable. As the authors re-reviewed the data points presented in the article, they identified differences between some of the plate reader values and those that were reported in the article. For some of the duplicates run, one of the values was indeed from the plate reader data, whereas the source of the counterpart value is not easily apparent. Therefore, because the authors could not replicate some of the counterpoint values, they cannot state if the data points represent the actual data generated in the experiments described. Furthermore, the duplicate values may not have been handled in the manner described within the Materials and Methods section of the paper and the values were not blanked. Taken together, the inconsistencies in validating the data collection and recordation warrant retraction of the article. The authors sincerely apologize for any inconvenience this might cause.
机译:应作者的要求,本文已撤回。他们认为该文章包含的结果可能不可靠。当作者重新审查文章中提供的数据点时,他们发现了一些酶标仪值和文章中报道的值之间的差异。对于某些重复运行,其中一个值确实来自于酶标仪数据,而对应值的来源并不容易看出。因此,由于作者无法复制某些对位值,因此他们无法说明数据点是否代表在所述实验中生成的实际数据。此外,可能没有按照本文的“材料和方法”部分所述的方式来处理重复值,并且未将这些值空白。综上所述,验证数据收集和记录方面的不一致会导致文章撤回。对于由此给您带来的任何不便,作者深表歉意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号